Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 8/20 | 0.37 |
| ▸ | HPGDS | O60760 | 3/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 5/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20484405 | 1.00 | PRCP (0.37) | PRCPHPGDSPRMT5GPR119SSTR3 | |
| SCHEMBL1293956 | 0.91 | HPGDS (0.38) | PRCPHPGDSSSTR3 | |
| SCHEMBL1293958 | 0.91 | HPGDS (0.38) | PRCPHPGDSSSTR3 | |
| SCHEMBL1293641 | 0.90 | HPGDS (0.37) | PRCPHPGDSSSTR3 | |
| SCHEMBL1293638 | 0.90 | HPGDS (0.37) | PRCPHPGDSSSTR3 | |
| SCHEMBL17938123 | 0.90 | HPGDS (0.37) | PRCPHPGDSSSTR3 | |
| SCHEMBL12104751 | 0.89 | HPGDS (0.38) | PRCPHPGDSSSTR3 | |
| SCHEMBL17249899 | 0.89 | HPGDS (0.38) | PRCPHPGDSSSTR3 | |
| SCHEMBL19414607 | 0.88 | HPGDS (0.37) | PRCPHPGDSSSTR3 | |
| SCHEMBL19702066 | 0.87 | PRCP (0.34) | PRCPSSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499127-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-09-05 | — | — | EP | disclosed |
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | BRISTOL MYERS SQUIBB CO (US) | 2017-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | HAVCR2, LIPC, PYGL | PRCP 220/4885HPGDS 679/4885PRMT5 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.